SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
3198.65
48.15 (1.53%)
VOLUME 22,780
LIVE
NSE
Dec 19, 16:30
3199.45
48.2 (1.53%)
VOLUME 476,395
Announcements on Dr Reddys Labs

19th-Dec-2014 12:16Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2014, titled "Dr. Reddy s Laboratories closes the acquisition of Habitrol Brand from Novartis".

19th-Dec-2014 10:41Source: BSE

Dr Reddys Labs- Dr. Reddy’s Laboratories closes the acquisition of Habitrol® Brand from Novartis

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated December 19, 2014 titled "Dr. Reddy’s Laboratories closes the acquisition of Habitrol® Brand from Novartis".

16th-Dec-2014 12:29Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated December 16, 2014 titled "Dr. Reddy s announces the Launch of Valganciclovir Tablets, USP".

16th-Dec-2014 11:45Source: BSE

Dr Reddys Labs- Dr. Reddy's announces the Launch of Valganciclovir Tablets, USP

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated December 16, 2014 titled "Dr. Reddy''s announces the Launch of Valganciclovir Tablets, USP".

15th-Dec-2014 14:41Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Abhishek Khadria has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

12th-Dec-2014 11:26Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Prabhakaran B Nair has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

12th-Dec-2014 09:25Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has submitted to the Exchange vide letter dated December 11, 2014 a copy of disclosures under Regulations 13(4), 13(4A) & 13(6) of SEBI (Prohibition of Insider Tradin...

11th-Dec-2014 18:23Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

11th-Dec-2014 16:10Source: NSE

Dr. Reddy's Laboratories Limited

The Exchange has sought clarification from Dr. Reddy''s Laboratories Limited with respect to news item captioned "Germany bans 80 generic drugs for insufficient trials". In this regard, Exchange have ...

10th-Dec-2014 14:23Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Ravi Prakash Mathur has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.